Delcath Systems, Inc. (DCTH) vs Pacific Biosciences of California, Inc. (PACB)
Delcath Systems, Inc. and Pacific Biosciences of California, Inc. are both Medical Devices companies. Delcath Systems, Inc. is the larger, with a market value of $558.0M against $484.9M — 1.2× the size. Pacific Biosciences of California, Inc. has negative trailing earnings, so its P/E is not meaningful; Delcath Systems, Inc. trades at 1,560×. Delcath Systems, Inc. grew revenue faster over the last twelve months: 35.9% against 2.02%. Delcath Systems, Inc. has the higher net margin (0.56% vs −82.5%) and the higher return on invested capital (−4.49% vs −22.2%). Across the 17 metrics below, Delcath Systems, Inc. leads on 14 and Pacific Biosciences of California, Inc. on 3.
Valuation
Profitability
| Metric | DCTH | PACB | Medical Devices median |
|---|---|---|---|
| Gross margin | 87.05% | 36.38% | 56.01% |
| Operating margin | (1.90%) | (83.53%) | (15.03%) |
| Net margin | 0.56% | (82.49%) | (20.40%) |
| Free cash flow margin | 18.35% | (50.53%) | (7.24%) |
| Return on equity | 0.47% | (929.31%) | (15.32%) |
| Return on assets | 0.42% | (16.66%) | (19.72%) |
| Return on invested capital | (4.49%) | (22.22%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack